A Study to Assess Safety and Effectiveness of Adalimumab for Treating Children and Adolescents With Crohn's Disease in Real Life Conditions
Study Identifier
P15-759
CT.gov Identifier
EudraCT Identifier
Not available
EUCTIS ID
Not available
For general inquiries, please contact
Results Available
Scientific Result Summary
Available Language(s): English
Study Details
Medical Condition
Study Drug
N/A
Phase
N/A
Sex
Female & Male
Age
6 - 17 Years
Protocol Summary
The primary objective of this study is to evaluate long-term effectiveness of adalimumab in pediatric participants starting a treatment for Crohn's disease in real life conditions, namely to describe the time to loss of clinical benefit in a time to event approach. Main secondary objectives are to describe growth and pubertal development and to describe long-term safety. The participants will be followed-up up to 10 years.
Study Locations
Location
Status
Location
Centre Hospitalier Lyon Sud /ID# 152667
Pierre-Bénite, Auvergne-Rhône-Alpes, France, 69495
Status
Not applicable
Location
Centre Hospitalier Lyon Sud /ID# 152668
Pierre-Bénite, Auvergne-Rhône-Alpes, France, 69495
Status
Not applicable
Location
Hopital Clocheville /ID# 152831
Tours, Centre-Val De Loire, France, 37044
Status
Not applicable
Location
CHU de Besancon - Jean Minjoz /ID# 154197
Besançon, Doubs, France, 25000
Status
Not applicable
Location
Hopitaux de Brabois Adultes /ID# 152729
Vandœuvre-lès-Nancy, Lorraine, France, 54500
Status
Not applicable
Location
CHU Toulouse /ID# 153251
Toulouse, Occitanie, France, 31025
Status
Not applicable
Showing {first} - {last} of {total} Results